Applications of single-molecule protein sequencing in precision oncology drug development
Protein variant characterization remains a central challenge in precision oncology, where understanding the functional consequences of sequence alterations can inform and drive therapeutic development. In this webcast, Dr Nigel O’Neil, Co-Founder and CSO of Arrowsmith Genetics, will discuss his team’s work in oncology drug development, highlighting the technical and biological hurdles encountered when working with […]